BACKGROUND
The use of unsupervised, app-based cognitive assessments provides considerable opportunities for early and comprehensive testing for Alzheimer’s disease, minimizing the demand on time and personnel resources in medical practices. However, the acceptance of such an app within healthcare has yet to be assessed.
OBJECTIVE
In this pilot study, we examined the acceptance of an app-based, repeated cognitive assessment for early symptoms of Alzheimer’s disease (neotivCare) in the outpatient care setting from both physicians’ and patients’ perspectives.
METHODS
Fifteen primary care practices participated, where patients with self- or relative-reported memory problems could be prescribed an app for comprehensive cognitive testing. Patients used the app to test their episodic memory function weekly for three months at home. After the testing period and the final consultation, physicians and patients received questionnaires to assess the app’s acceptance.
RESULTS
We received completed questionnaires from physicians for 45 patients. Additionally, we received 45 completed questionnaires from the patients themselves. The physicians reported that, for most patients, the app supported their decision-making in the diagnostic process (58%). Additionally, most physicians found the app’s information dependable (75%) and felt more certain in their decisions (84%). From the patients’ perspective, a majority felt thoroughly tested (76%), and only a few considered the time commitment for the cognitive tests to be too burdensome (15%). Moreover, despite the weekly cognitive testing and the lengthy twelve-week testing period, a majority of patients participated in all tests (72%).
CONCLUSIONS
Our pilot study indicates a high acceptance of an app for unsupervised, app-based cognitive testing over an extended period from both the participating physicians’ and patients’ perspectives. These initial findings suggest that unsupervised app-based cognitive assessment can be integrated into healthcare.
CLINICALTRIAL
not applicable